Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study

Código QR

Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study

Aim. To investigate the efficacy and safety of combined glimepiride and metformin therapy in patients with type 2 diabetes mellitus (T2DM). Materials and methods. A multi-centre, open-label, prospective, observational study was conducted. A total of 1200 patients with T2DM inadequately controlled...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Natalya Vladislavovna Zaytseva, Ivona Renata Jarek-Martynova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2015
Materias:	glycated haemoglobin diabetes mellitus glimepiride metformin Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/01731ff43c654097a49be8c4ae30be69
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Assessment of Clinical Experience of Triple Drug Fixed-dose Combination of Glimepiride, Metformin and Voglibose in the Management of Type 2 Diabetes Mellitus: A Retrospective Study
por: Ganapathi Bantwal, et al.
Publicado: (2021)

Efficacy and safety of glimepiride as initial treatment in Russian patients with type 2 diabetes mellitus
por: Alexander Sergeevich Ametov, et al.
Publicado: (2013)

Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus
por: Xie J, et al.
Publicado: (2019)

Modern antihyperglycemic therapy: safety and efficacy of glimepiride
por: Lyudmila Alexandrovna Ruyatkina, et al.
Publicado: (2012)

Initial investigation of efficacy and safety of a new dipeptidyl peptidase-4 inhibitor, gosogliptin, for type 2 diabetes in Russia
por: Lyudmila Viktorovna Nedosugova, et al.
Publicado: (2014)

Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride
por: Tatiana Ivanovna Romantsova, et al.
Publicado: (2010)

Metformin and cancer mortality
por: Lev Mikhaylovich Bershteyn
Publicado: (2010)

Prevalence of type 2 diabetes mellitus and its complications among the population of Moscow Region ? a cross-sectional epidemiological study
por: Yury Ivanovich Suntsov, et al.
Publicado: (2013)

DEVELOPMENT AND VALIDATION OF HPTLC DENSITOMETRY METHOD FOR SIMULTANEOUS ESTIMATION OF ROSIGLITAZONE AND GLIMEPIRIDE IN FIXED TABLET DOSAGE FORM
por: DHOLE,SEEMA M, et al.
Publicado: (2013)

Multidimensional effects of metformin in patients with type 2 diabetes
por: Lyudmila A. Ruyatkina, et al.
Publicado: (2017)

Efficacy and safety of metformin for the treatment of gestational diabetes: a new approach to the problem
por: Anna I. Sazonova, et al.
Publicado: (2016)

Metformin effects to carbohydrate and lipids metabolism in impaired glucose tolerance patients.
por: Alexander Vasil'evich Dreval', et al.
Publicado: (2010)

Russian Association of Endocrinologists reports commencement of Amaril clinical use
por: Editorial team Diabetes Mellitus
Publicado: (2012)

Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
por: Alexander Sergeevich Ametov, et al.
Publicado: (2010)

Russian Association of Endocrinologists reports commencement of Glimecomb clinical use
por: Editorial team Diabetes Mellitus
Publicado: (2011)

Pharmacoeconomic analysis of clinical efficiency of combined metformin (Siofor) - insulin therapy in patients with type 2 diabetes mellitus
por: I Yu Demidova, et al.
Publicado: (2009)

Efficiency and safety of transfer of type 2 diabetes patients inadequately controlled on metformin alone to combined therapy with metformin and diabeton MB
por: Alexander Sergeevich Ametov, et al.
Publicado: (2009)

Phenotypic and genetic characteristics of patients with type 2 diabetes with different responses to metformin therapy in Novosibirsk region
por: Irina A. Bondar, et al.
Publicado: (2016)

The role of iron metabolism indicators in predicting gestational diabetes mellitus
por: A. O. Torosyan, et al.
Publicado: (2021)

Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment
por: Tatiana Ivanovna Romantsova, et al.
Publicado: (2013)

Novosti fundamental'nykh issledovaniy
por: Ivona Renata Yarek-Martynova, et al.
Publicado: (2008)

The role of metformin in the modern strategy of treatment and prevention of type 2 diabetes mellitus
por: Olga Mikhailovna Smirnova
Publicado: (2010)

Po materialam 44 kongressa Evropeyskoy Assotsiatsii po izucheniyu diabeta (EASD), Rim, 8-11 sentyabrya 2008 g. i spetsial'nogo vypuska Diabetologia, № 51 [Suppl 1], sentyabr' 2008 g.
por: Ivona Yanovna Yarek-Martynova
Publicado: (2008)

Metformin in patients with ischemic heart disease and type 2 diabetes mellitus: mechanism of action and clinical efficiency
por: Ekaterina Nikodimovna Kravchuk, et al.
Publicado: (2013)

Improved oral bioavailability of poorly water-soluble glimepiride by utilizing microemulsion technique
por: Li HY, et al.
Publicado: (2016)

Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer
por: Lev Mikhaylovich Bershteyn, et al.
Publicado: (2014)

Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation program
por: Marina Vladimirovna Shestakova
Publicado: (2010)

International guidelines on the study of glycated hemoglobin HbA1c level as a diagnostic criterion for diabetes mellitus and otherdisorders of carbohydrate metabolism
por: Gagik Radikovich Galstyan
Publicado: (2010)

Factors associated with abnormal cardio-ankle vascular index in patients with type 2 diabetes and prediabetes
por: Aleksei N. Sumin, et al.
Publicado: (2016)

Mechanistic analysis of Zein nanoparticles/PLGA triblock in situ forming implants for glimepiride
por: Ahmed OAA, et al.
Publicado: (2016)

Comparison of Serum Vitamin B12 Levels in Type 2 Diabetes Mellitus Patients with and without Diabetic Retinopathy: A Case-control Study
por: Supriya, et al.
Publicado: (2021)

Carbohydrate metabolism in menopausal women
por: Olga Rafael'evna Grigoryan, et al.
Publicado: (2009)

Glucose-lowering therapies in patients with diabetes mellitus and chronic kidney disease
por: Minara Shamkhalovna Shamkhalova, et al.
Publicado: (2013)

Glycated hemoglobin test: diagnostic difficulties in gestational diabetes
por: Tatiana Vladimirovna Saprina, et al.
Publicado: (2012)

American Diabetes Association proposes to use HbA1c level for diagnosis of diabetes mellitus
por: Olga Yur'evna Sukhareva
Publicado: (2009)

Liraglutide for Weight Management in the Real World: Significant Weight Loss Even if the Maximal Daily Dose Is Not Achieved
por: Liesbet Trenson, et al.
Publicado: (2021)

Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition
por: Rahim H, et al.
Publicado: (2019)

Evaluation of the degree of metabolic compensation and prevalence of diabetic complications in a Russian population of childrenand adolescents (results of the ?Screening for diabetic complications and assessment of medical aid to diabetic patients? Project)
por: Ekaterina Andreevna Andrianova, et al.
Publicado: (2009)

Statin use and risk of diabetes mellitus
por: Oksana Mikhailovna Drapkina, et al.
Publicado: (2012)

Fabrication and Characterization of Glimepiride Nanosuspension by Ultrasonication-Assisted Precipitation for Improvement of Oral Bioavailability and in vitro α-Glucosidase Inhibition [Corrigendum]
por: Rahim H, et al.
Publicado: (2020)